EMILY BROOKBANK: Open Payments
NPI 1841615457 · BATAVIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 32 payments from 14 companies in 2025. Trend: 2023 $2,213 · 2024 $1,210 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $198 |
| Calyxo, Inc. | 1 | $161 |
| Medtronic, Inc. | 3 | $161 |
| Boston Scientific Corporation | 1 | $149 |
| Dendreon Pharmaceuticals LLC | 4 | $140 |
| Sumitomo Pharma America, Inc. | 4 | $90 |
| IMMUNITYBIO, INC. | 3 | $60 |
| UROGEN PHARMA, INC. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Teleflex LLC | 1 | $34 |
Products named: ADSTILADRIN, CVAC ASPIRATION SYSTEM, Axonics, INTERSTIM, PROVENGE, GEMTESA, ANKTIVA, JELMYTO.
Industry payments across OH — which companies pay providers there.
